Charles Schwab Investment Management Inc Revolution Medicines, Inc. Transaction History

Charles Schwab Investment Management Inc

$527 Billion
Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,931,114 shares of RVMD stock, worth $78.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,931,114

Previous 1,763,117 9.53%

Holding current value

$78.5 Million

Previous $79.9 Million 5.73%

% of portfolio

0.02%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$42.97 - $60.6 $7.22 Million - $10.2 Million	167,997 Added 9.53%	1,931,114 $84.5 Million
Q3 2024 Nov 12, 2024	BUY	$36.92 - $47.94 $24.1 Million - $31.3 Million	653,433 Added 58.88%	1,763,117 $79.9 Million
Q2 2024 Aug 12, 2024	BUY	$30.14 - $40.68 $1.73 Million - $2.34 Million	57,421 Added 5.46%	1,109,684 $43.1 Million
Q1 2024 May 08, 2024	BUY	$26.56 - $33.55 $246,901 - $311,880	9,296 Added 0.89%	1,052,263 $33.9 Million
Q4 2023 Feb 06, 2024	BUY	$18.35 - $34.12 $5.07 Million - $9.43 Million	276,298 Added 36.04%	1,042,967 $29.9 Million
Q3 2023 Nov 08, 2023	BUY	$25.17 - $35.05 $1.4 Million - $1.95 Million	55,558 Added 7.81%	766,669 $21.2 Million
Q2 2023 Aug 09, 2023	BUY	$20.28 - $27.0 $1.09 Million - $1.45 Million	53,884 Added 8.2%	711,111 $19 Million
Q1 2023 May 11, 2023	BUY	$20.76 - $30.09 $1.95 Million - $2.83 Million	94,140 Added 16.72%	657,227 $14.2 Million
Q4 2022 Feb 13, 2023	BUY	$17.68 - $25.53 $401,601 - $579,913	22,715 Added 4.2%	563,087 $13.4 Million
Q3 2022 Nov 14, 2022	BUY	$17.46 - $26.0 $1.68 Million - $2.5 Million	95,969 Added 21.6%	540,372 $10.7 Million
Q2 2022 Aug 15, 2022	BUY	$14.54 - $27.17 $2,777 - $5,189	191 Added 0.04%	444,403 $8.66 Million
Q1 2022 May 13, 2022	BUY	$17.31 - $26.4 $227,349 - $346,737	13,134 Added 3.05%	444,212 $11.3 Million
Q4 2021 Feb 11, 2022	BUY	$24.35 - $33.7 $127,545 - $176,520	5,238 Added 1.23%	431,078 $10.9 Million
Q3 2021 Nov 16, 2021	BUY	$23.95 - $33.41 $1.7 Million - $2.37 Million	70,898 Added 19.97%	425,840 $11.7 Million
Q2 2021 Aug 16, 2021	BUY	$29.0 - $47.44 $1.16 Million - $1.9 Million	40,136 Added 12.75%	354,942 $11.3 Million
Q1 2021 May 17, 2021	BUY	$37.21 - $54.43 $1.78 Million - $2.6 Million	47,735 Added 17.87%	314,806 $14.4 Million
Q4 2020 Feb 16, 2021	BUY	$30.19 - $45.49 $76,441 - $115,180	2,532 Added 0.96%	267,071 $10.6 Million
Q3 2020 Nov 13, 2020	BUY	$22.61 - $34.8 $3.78 Million - $5.81 Million	167,008 Added 171.24%	264,539 $9.21 Million
Q2 2020 Aug 14, 2020	BUY	$19.65 - $39.34 $1.33 Million - $2.66 Million	67,650 Added 226.4%	97,531 $3.08 Million
Q1 2020 May 15, 2020	BUY	$20.0 - $34.08 $597,620 - $1.02 Million	29,881 New	29,881 $655,000

Others Institutions Holding RVMD

# of Institutions

298

Shares Held

179M

Call Options Held

920K

Put Options Held

1.06M

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.57B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Revolution Medicines, Inc. Transaction History